Biological medicine high investment, high risk, high return, long development cycle development characteristic, the led industry development must achieve three agglomeration: the park gathering, gathering to economically developed regions, to professional concentration areas of intelligence gathering. Biological medicine industrial park in China is accompanied by the development and the continuous development of the high and new technology. At present our country gradually formed by the Yangtze river delta, the pearl river delta and the beijing-tianjin-hebei region three comprehensive biological industry base, and several professional biological industry base in northeast China, the central and western regions of space layout, promote biological elements such as enterprises, capital, technology, talent to advantage area, accelerating the development of biological industry to cluster, the characterization. 
 
 
With the vigorous development of the biomedical industry in China, more and more foreign pharmaceutical companies to set up r&d centers in China, foreign-invested enterprises become an important part of biological science and technology park. So, foreign pharmaceutical giant biological park of China's existing evaluation? 
 
 
Published in January 2015 the first phase of Nature Review Drug Discovery ", published astrazeneca chinese-foreign cooperation in Asia and emerging markets, executive director of Ajay Gautam according to the statistical data for the assessment of biological science and technology park development present situation of China, and combining with development of each park respectively gives the corresponding Suggestions. Ajay Gautam according to the construction of China's biological science and technology park, will China's biological science and technology park according to the characteristics of geographical distribution is divided into eight, namely: 

1. Shanghai biological science and technology park (east coast) 
 
 
2. Suzhou - nanjing biotechnology park (east coast) 
 
 
3. Beijing - tianjin biological science and technology park (north) 
 
 
4. Shenzhen - guangzhou biological science and technology park (southeast) 
 
 
5. Wuhan biological science and technology park (east) 
 
 
6. Chengdu biological science and technology park (southwest) 
 
 
7. Biological science and technology park in kunming, southwest) 
 
 
8. Changchun - Harbin biological science and technology park (northeast China) 
 
 
Eight park development status of the above evaluation, mainly from the Entrepreneurial Index (business Index) and Academic Index (Index) for two dimensional analysis. Entrepreneurial Index (business Index) consists of two indicators: 1) the park has a number of biotech companies risk investment background; 2) the number of contract research organization in the park. Academic Index (Academic Index) consists of two indicators: 1) the park SCI papers published by reference conditions (data from the China science and technology information institute of China statistical results of scientific papers in 2012; 2) the park's top universities (top universities defined as China's ministry of education to assess 211 university and the university of 985, data from the Chinese ministry of education published in 2012). 
 
 
 
                        Table 1 eight major domestic biological science and technology park business and academic index evaluation 

Figure 1 eight big domestic current situation of the development of biological science and technology park 

     Integrated computation of eight park Entrepreneurial Index (business Index) and Academic Index (Academic Index), Ajay Gautam zone can be divided into four types: 
Innovation leader (Innovation) Leaders such as Shanghai, Beijing, tianjin, suzhou, nanjing biological science and technology park. The three biological science and technology park Entrepreneurial Index (business Index) and Academic Index (Academic Index) is very high. So for the domestic innovation leader of biological science and technology park. For this type of biological science and technology park, need government support from policy, capital, etc in order to maintain the status of industry leader. Such as increased funding for universities, research institutes, increase policy support for emerging enterprises, enhance r&d infrastructure construction, promote the talent training, etc. 
Talent (Untapped Talent) such as wuhan biological science and technology park, the park's Academic Index (Academic Index) is very high, has the rich research achievements, a lot of high-quality scientific research personnel, but lack of transformation of scientific achievements, not form a good market docking. For this type of biological science and technology park, the key to take various measures to promote the transformation of scientific and technological achievements, such as strengthening the construction of early risk investment, enterprise incubation base and so on. 
Industrial base (Niche hubs), such as shenzhen, guangzhou biological science and technology park, the park Entrepreneurial Index (business Index) is very high, but the Academic Index (Academic Index) is relatively weak. For this type of biological science and technology park, to strengthen the construction of academic, to improve the quality of the talents and level. As the academic index of biological science and technology park ascend, leaders can become more creative, so as to play a bigger role. 
Rookie (Aspiring) such as kunming, changchun, Harbin, chengdu biological science and technology park, the park because of the development time is shorter, Entrepreneurial Index (business Index) and Academic Index (Academic Index) are at a lower level. For this type of biological science and technology park, the need to develop long-term development planning, gradually raising the level of strength and in park. 
But it is worth noting that the foreign pharmaceutical enterprise in China to evaluate biological park, more from the perspective of the foreign capital enterprise own development, so the selection of evaluation index number more from foreign companies, CRO company quantity, SCI citations, number of top universities, etc. Therefore the evaluation mode only from a certain extent, reflects the state of domestic biological science and technology park, does not represent the whole picture of biological science and technology park in China.